HHS aims to use value-based care payment models to lower drug prices

September 9, 2021Garrett SchmittNo CommentsCMMI, drug prices, HHS, Pharmaceuticals

The Department of Health and Human Services wants to test models that would pay drugs based on their clinical value as part of a new plan to tackle high prices. The plan released Thursday lays out several administrative tools the agency plans to take to address high prices. It also calls on Congress to adopt several reforms…

Recent Posts

  • RECORDED WEBINAR: How To Build Your Own Clinical Student Workforce For Care Gap Closure
  • Strides toward interoperability, AI improve value-based care
  • Discover Cost Drivers in TEAM Surgeries
  • 14.3 million Medicare beneficiaries now in ACOs: 6 notes
  • CMS’ Roadmap for Switching to FHIR-Based Digital Quality Measures
 
  • Main Lobby
  • Exhibit Hall
  • Events
  • Exhibit With Us
  • Board Room
  • Library
  • Contact Us